Other agents and products
DXM combinations with substances in this group.
PHI is a provisional hazard rating for a combination with DXM on a 0–10 scale.
- No PHI rating
Why is there no PHI rating?
The review leaves PHI unassigned for DXM with 5-HTP because data for a numerical comparison are insufficient.
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
- No PHI rating
Why is there no PHI rating?
The review gives this DXM combination no PHI. Mirtazapine, buspirone, triptans and cyclobenzaprine differ in pharmacology and main concerns.
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
- No PHI rating
Why is there no PHI rating?
A combination medicine contains DXM and other active ingredients. Acetaminophen, chlorphenamine, sedating antihistamines and sympathomimetic decongestants can cause their own toxic effects as more of the product is taken. Most cards assess DXM with one other substance; a combination medicine requires accounting for all its ingredients [6, 7, 25]. Extended release also changes how long the substances act together.
Full explanation from the review
DXM alone must be distinguished from combination medicines. Acetaminophen (paracetamol), chlorphenamine, sedating antihistamines, and sympathomimetic decongestants can create their own toxicity when more of the product is taken. These ingredients place the product outside most two-substance rows [6, 7, 25]. Extended-release formulations also alter the duration of overlapping effects.
- No PHI rating
Why is there no PHI rating?
The review gives this DXM combination no PHI. Mirtazapine, buspirone, triptans and cyclobenzaprine differ in pharmacology and main concerns.
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
- No PHI rating
Why is there no PHI rating?
Alkaloid concentrations in Datura and Atropa belladonna vary, so the amount of plant material does not reliably indicate the amount of active substances. The review excludes these plants from numerical PHI scoring because that scoring assumes a known exposure to the active substance [35].
Full explanation from the review
Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44]. Datura and Atropa belladonna are excluded because variable alkaloid concentrations undermine the known-exposure assumption [35]. Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31]. Their concerns are discussed in Sections 5 and 8.
- No PHI rating
Why is there no PHI rating?
The review leaves PHI unassigned for DXM with lithium because data for a numerical comparison are insufficient.
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
- No PHI rating
Why is there no PHI rating?
Piracetam, DMAE, and lecithin are excluded from the numerical matrix. The FAQ contains accounts of subjective memory improvement, but evidence is insufficient to treat them as protection against physical injury.
- No PHI rating
Why is there no PHI rating?
Full explanation from the review
Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44]. Datura and Atropa belladonna are excluded because variable alkaloid concentrations undermine the known-exposure assumption [35]. Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31]. Their concerns are discussed in Sections 5 and 8.
- No PHI rating
Why is there no PHI rating?
The review leaves PHI unassigned for DXM with St John’s wort because data for a numerical comparison are insufficient. ACMT lists St John’s wort as a possible interacting agent, without a numerical estimate for this pair [25].
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
- No PHI rating
Why is there no PHI rating?
Triptans differ in pharmacology; the review leaves PHI unassigned for their DXM combinations. ACMT lists triptans as possible interacting agents, without numerical estimates for individual pairs [25].
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
- No PHI rating
Why is there no PHI rating?
The review leaves PHI unassigned for DXM with tryptophan because data for a numerical comparison are insufficient.
Full explanation from the review
Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.
Find combinations by mechanism
Here the combinations are grouped by interaction mechanism.
Serotonin-related
This category is not marked in the review
Cardiovascular and thermal
This category is not marked in the review
Sedation and respiration
This category is not marked in the review
Metabolism
This category is not marked in the review
NMDA
This category is not marked in the review
Antimuscarinic
This category is not marked in the review
Seizure-related concern
This category is not marked in the review
Other discussed pathways
This category is not marked in the review